Snapshot · On Purpose with Jay Shetty
Harvard social psychologist Dan Gilbert found people consistently underestimate how much they will change in the future while acknowledging how much they've changed in the past.
Where this was said
At 54:03 · chapter starts 53:23
Jay asks whether Lucy was always this evolved or whether grief accelerated her. She credits medical school — which demanded she deploy every fiber of her intellectual and emotional capacity — and a painful episode of depression during residency as the two most formative experiences. She quotes Andrew Solomon: depression is not the opposite of happiness but the opposite of vitality. She then introduces Dan Gilbert's Harvard research on the end of history illusion — people at every age report having changed enormously in the past decade, but expect to barely change in the next, even though the data shows they always do. Jay recognizes himself in this: he thought he knew who he was 10 years ago, which is exactly the illusion. The insight: the self is always under construction.
Harvard psychologist Dan Gilbert found that people at every age believe they've changed enormously in the past 10 years but will barely change in the next. This 'end of history illusion' is universal — everyone keeps changing at the same rate throughout life. The self is never done.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.